Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

P Mariappan; Z Ballantyne; J M O N'Dow; A A Alhasso

doi:10.1002/14651858.CD004742.pub2

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

P Mariappan, Z Ballantyne, J M O N'Dow, A A Alhasso

Research output: Contribution to journal › Article › peer-review

113 Citations (Scopus)

Abstract

To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.

Original language	English
Pages (from-to)	CD004742
Journal	Cochrane Database of Systematic Reviews
Issue number	3
DOIs	https://doi.org/10.1002/14651858.CD004742.pub2
Publication status	Published - 2005

Access to Document

10.1002/14651858.CD004742.pub2

Cite this

@article{d195feecafdd47e0b3635100bc408fbe,

title = "Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults",

abstract = "To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.",

author = "P Mariappan and Z Ballantyne and N'Dow, {J M O} and Alhasso, {A A}",

year = "2005",

doi = "10.1002/14651858.CD004742.pub2",

language = "English",

pages = "CD004742",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "3",

}

TY - JOUR

T1 - Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

AU - Mariappan, P

AU - Ballantyne, Z

AU - N'Dow, J M O

AU - Alhasso, A A

PY - 2005

Y1 - 2005

N2 - To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.

AB - To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.

U2 - 10.1002/14651858.CD004742.pub2

DO - 10.1002/14651858.CD004742.pub2

M3 - Article

C2 - 16034945

SN - 1469-493X

SP - CD004742

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 3

ER -

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

Abstract

Access to Document

Fingerprint

Cite this